ICUI - Latest News

ICU Medical, Inc. (ICUI), operates in Healthcare / Medical - Instruments & Supplies, trades on NASDAQ.

Market capitalization stands near $4.48B. Trailing twelve-month P/E ratio is 74.31. Beta to the broader market is 0.76.

The article list below shows the most recent ICUI headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent ICUI Headlines

ICU Medical to Present at the 2026 Jefferies Global Healthcare Conference in London

globenewswire.com - Nov 6, 2026

SAN CLEMENTE, Calif. , Nov.

ICU Medical Q3 Earnings Call Highlights

marketbeat.com - Nov 6, 2026

ICU Medical NASDAQ: ICUI reported third-quarter revenue of $556 million and said it expects full-year adjusted earnings to finish toward the high end

ICU Medical (ICUI) Beats Q3 Earnings and Revenue Estimates

zacks.com - Nov 6, 2026

ICU Medical (ICUI) came out with quarterly earnings of $2. 44 per share, beating the Zacks Consensus Estimate of $2.

ICU Medical (ICUI) Reports Q3 Earnings: What Key Metrics Have to Say

zacks.com - Nov 6, 2026

The headline numbers for ICU Medical (ICUI) give insight into how the company performed in the quarter ended September 2026, but it may be worthwhile

ICU Medical, Inc. (ICUI) Q3 2026 Earnings Call Transcript

seekingalpha.com - Nov 5, 2026

ICU Medical, Inc.

How News Affects ICUI Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track ICUI's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked ICUI news questions

What is the latest ICUI news headline?
The most recent ICUI headline (Nov 6, 2026) is "ICU Medical to Present at the 2026 Jefferies Global Healthcare Conference in London". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.
How fresh is the ICUI news on this page?
News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.
What ICUI news moves options pricing?
Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.
How can I track unusual ICUI options activity related to news?
Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.